Blood antibodies may predict HPV-positive oropharyngeal cancer survival

(American Association for Cancer Research) The presence of certain human papillomavirus (HPV)-16 antibodies in the blood was associated with improved rates of survival among patients with HPV-related oropharyngeal carcinoma.